In a report released today, J. Parker Lane from Stifel Nicolaus maintained a Hold rating on Twilio (TWLO – Research Report), with a price ...

Stifel Nicolaus analyst Jim Duffy reiterated a Buy rating on Lululemon Athletica (LULU – Research Report) today and set a price target of ...

Stifel Financial (SF) came out with quarterly earnings of $2.23 per share, beating the Zacks Consensus Estimate of $1.97 per share. This compares to earnings of $1.50 per share a year ago.

Stifel Financial Corp. announced a cash dividend of $0.46 per share on its common stock, payable on March 17, 2025, to shareholders recorded by March 3, 2025. Additionally, the company declared ...

January 28, 2025 Chris O'Cull, analyst from investment company Stifel Nicolaus, reiterated Buy rating on Starbucks (NASDAQ:SBUX) today and increased the price target from $110 to $114. The market ...

Swimming against the flow of advisors leaving wirehouses, a three-person team formerly managing $12 billion at Stifel has moved to Morgan Stanley. Ari Spar, Justin Bell and John Magovern have ...

Investing.com -- Stifel upgraded Portillo's Inc (NASDAQ:PTLO) to Buy from Hold on company’s renewed focus on addressing traffic challenges and its potential for improved performance. Brokerage ...

Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with ...

Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...